By Mark Terry for Biospace Biopharma companies large and small are involved in numerous clinical trials. Here’s a look at some of the top stories from last week. Kalytera Therapeutics announced interim data from its Phase II clinical trial of cannabidiol (CBD) for the...
– Trial leads to discovery that onvansertib stops rise in PSA in patients with treatment-resistant, highly-aggressive and difficult-to-treat androgen-receptor variant 7 (AR-V7) tumors – Data demonstrates efficacy of onvansertib in patients showing early...
CStone Pharmaceuticals (“CStone”, HKEX: 2616) today announced that the first patient in China has been dosed in the Phase I/II bridging study of avapritinib, which was discovered by CStone’s partner Blueprint Medicines. This stand-alone...
California Institute for Regenerative Medicine awarded a $9.28 million grant will support a clinical trial at City of Hope to evaluate chimeric antigen receptor T-cell therapy for patients with HER2-positive breast cancer that spread to the brain. About 20% of breast...
A proposed treatment of HIV that could be administered once every two months rather that a one-month treatment has met the “primary endpoint” in a late-phase clinical trial, ViiV Healthcare announced Thursday. It’s just as effective – “similar efficacy” i.e....
Phase 2 clinical trial of Saroglitazar Magnesium in NAFLD with PCOS Image credit- istock.com Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has initiated a Phase 2 clinical trial for evaluating the effect of Saroglitazar Mg in the...
Email
Text